Indivior Pharmaceuticals, Inc. (INDV) Shareholders’ equity 2022–2025
Indivior Pharmaceuticals, Inc. (INDV) shareholders’ equity at each fiscal year-end, per SEC filings.
-$98.0MFY2025 · since FY2022: -$15.0M → -$98.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$98.0M | +70.9% |
| FY2024 | -$337.0M | -83.2% |
| FY2023 | -$184.0M | -1126.7% |
| FY2022 | -$15.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice